ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

23.06
1.28
(5.88%)
Closed March 01 3:00PM
22.75
-0.31
(-1.34%)
After Hours: 6:55PM

Rigel Pharmaceuticals Inc Financial Summary

The current RIGL market cap is 400.74M. The company's latest EPS is USD -1.4244 and P/E is -16.22.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 28.13M35.79M29.53M36.84M55.31M
Operating Income -4.47M1.97M-6.97M447k14.06M
Net Income -5.69M737k-8.25M-1.03M12.42M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 59.29M108.62M149.24M120.24M116.88M
Operating Income -69.09M-28.97M-12.5M-55.55M-20.49M
Net Income -66.89M-29.74M-17.91M-58.57M-25.09M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 115.32M117.23M126.52M128.41M139.42M
Total Liabilities 147.16M145.87M158.19M158.32M154.06M
Total Equity -31.83M-28.64M-31.67M-29.91M-14.64M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 147.57M110.38M167.33M134.28M117.23M
Total Liabilities 93.75M76.35M136.95M147.9M145.87M
Total Equity 53.82M34.03M30.37M-13.62M-28.64M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 497k-5.74M-5.01M-4.71M16.97M
Investing 2.58M-4.3M313k11.24M15.04M
Financing 17.88M18.37M-2.51M-3.26M-13.11M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -41.51M-52.19M5.88M-73.76M-5.74M
Investing -23.66M47.47M-80.04M72.78M-4.3M
Financing 11.37M12.57M62.68M6.55M18.37M
Market Cap 400.74M
Price to Earnings Ratio -16.22
Price to Sales Ratio 3.48
Price to Cash Ratio 12.42
Price to Book Ratio -14.21
Dividend Yield -

Share Statistics

Shares Outstanding 17.62M
Average Volume (1 week) 190.76k
Average Volume (1 Month) 241.83k
52 Week Change 51.67%
52 Week High 29.82
52 Week Low 7.4843
Spread (Intraday) 1.89 (7.65%)

Company Info

Company Name Rigel Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.rigel.com
Industry pharmaceutical preparations (2834)